Physician profile
Ben O Donovan
NPI 1760533533
$1,077.85
in general payments reported to CMS, 2019-2025
24 companies · $301 in 2025
The $301 reported for 2025 was more than what 75% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.99 · 2020: $199 · 2021: $80.85 · 2022: $124 · 2023: $192 · 2024: $129 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $213.27 | 2020-2023 | |
| Ferring Pharmaceuticals INC. | $136.82 | 2024-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $100.97 | 2020-2021 | |
| Calyxo, INC. | $66.62 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $50.18 | 2021-2023 | Gentlecath Glide |
| Teleflex LLC | $47.95 | 2023-2024 | Deflux, Urolift |
| Baxter Healthcare | $44.23 | 2023 | Floseal |
| Laborie Medical Technologies Corp. | $35.60 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Boston Scientific Corporation | $33.64 | 2019-2020 | |
| Blue Earth Diagnostics | $33.47 | 2025 | Posluma |
| Procept Biorobotics Corporation | $32.72 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $32.33 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $25.68 | 2024 | |
| Axonics, INC. | $25.02 | 2023 | Axonics |
| Novartis Pharmaceuticals Corporation | $24.85 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $24.45 | 2024 | |
| Abbvie INC. | $23.31 | 2024 | |
| Abbott Laboratories | $23.20 | 2022 | |
| Valencia Technologies Corporation | $22.05 | 2023 | Ecoin Device Kit |
| Sun Pharmaceutical Industries INC. | $20.19 | 2019 | |
| Olympus America INC. | $18.22 | 2025 | Itind System |
| C. R. Bard, INC. & Subsidiaries | $14.94 | 2020 | |
| Endo Pharmaceuticals INC. | $14.91 | 2020 | |
| Dendreon Pharmaceuticals LLC | $13.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.